Ovarian cancer can be influenced by inherited genetic mutations that increase a woman’s risk of developing the disease. While ovarian cancer can occur in women without any family history, a significant portion of cases are linked to specific genetic mutations. Understanding the genes involved is crucial for genetic counseling, risk assessment, and early detection.
Here’s an overview of the most important genes related to ovarian cancer:
Gene Function: BRCA1 is a tumor suppressor gene that plays a crucial role in repairing DNA damage. If this gene is mutated, the DNA repair mechanism is impaired, leading to an accumulation of genetic errors that can contribute to cancer development.
Ovarian Cancer Risk: Women with a BRCA1 mutation have a significantly higher risk of developing ovarian cancer. The lifetime risk for ovarian cancer in women with a BRCA1 mutation ranges from 39% to 46%, compared to the general population risk of around 1.3%. These women are also at a higher risk for breast cancer.
Gene Function: Like BRCA1, BRCA2 is involved in DNA repair, specifically repairing breaks in DNA strands. Mutations in BRCA2 lead to similar risks of impaired DNA repair and cancer development.
Ovarian Cancer Risk: Women with BRCA2 mutations are also at a significantly higher risk of ovarian cancer. The lifetime risk for ovarian cancer in women with a BRCA2 mutation ranges from 10% to 20%. BRCA2 mutations are also associated with an increased risk of breast cancer.
Gene Function: Lynch syndrome is caused by mutations in genes responsible for repairing DNA mismatch errors. These include the MLH1, MSH2, MSH6, and PMS2 genes.
Ovarian Cancer Risk: Women with Lynch syndrome have an increased risk of several cancers, including ovarian cancer, colorectal cancer, and endometrial (uterine) cancer. The lifetime risk of ovarian cancer for women with Lynch syndrome is around 10% to 15%, higher than the general population risk.
Gene Function: RAD51C and RAD51D are involved in the repair of damaged DNA, particularly in maintaining the integrity of the genetic material during cell division.
Ovarian Cancer Risk: Mutations in RAD51C and RAD51D are associated with an increased risk of ovarian cancer. Women with mutations in these genes have a moderate risk of ovarian cancer, similar to that seen with BRCA2 mutations, but the mutations are less common.
Gene Function: PALB2 works with BRCA2 in DNA repair. It helps to stabilize the BRCA2 protein and assists in repairing double-strand breaks in DNA.
Ovarian Cancer Risk: Mutations in PALB2 have been shown to increase the risk of both breast and ovarian cancers. Women with a PALB2 mutation are at a moderate to high risk of ovarian cancer, similar to BRCA2 mutation carriers.
Gene Function: BRIP1 plays a role in the repair of damaged DNA and interacts with BRCA1 in this process. Mutations in BRIP1 impair DNA repair mechanisms, contributing to cancer development.
Ovarian Cancer Risk: Women with mutations in the BRIP1 gene are at an increased risk of developing ovarian cancer, particularly high-grade serous ovarian cancer, the most common subtype. The lifetime risk is lower than that for BRCA1 and BRCA2 mutations but still significant.
Gene Function: STK11 is involved in regulating cell growth and division, and mutations in this gene can lead to tumor formation by disrupting normal cell cycle control.
Ovarian Cancer Risk: STK11 mutations are associated with Peutz-Jeghers syndrome, a rare inherited condition that increases the risk of several cancers, including ovarian cancer. Women with Peutz-Jeghers syndrome have an elevated risk for ovarian sex cord-stromal tumors.
Gene Function: TP53 is known as the "guardian of the genome" because it helps prevent cancer by controlling cell division and initiating cell death in damaged cells. Mutations in TP53 can lead to uncontrolled cell growth and cancer.
Ovarian Cancer Risk: Mutations in TP53 are common in various types of cancer, including ovarian cancer. While TP53 mutations are typically found in sporadic ovarian cancers, they are also seen in hereditary conditions like Li-Fraumeni syndrome, which significantly increases the risk of multiple cancers, including ovarian cancer.
Gene Function: XPF is involved in the repair of damaged DNA, particularly the repair of DNA crosslinks. Mutations in this gene affect the body’s ability to fix DNA damage, increasing the likelihood of cancer development.
Ovarian Cancer Risk: Mutations in the XPF gene can lead to an increased risk of ovarian cancer. This gene is part of the family of DNA repair genes associated with Fanconi anemia and other related syndromes that increase the risk of ovarian and other cancers.
Gene Function: The MUTYH gene is responsible for repairing oxidative damage to DNA. Mutations in this gene compromise the ability to fix DNA damage, which can lead to cancer.
Ovarian Cancer Risk: While MUTYH mutations are most often linked to colorectal cancer, there is some evidence that mutations in this gene may also increase the risk of developing ovarian cancer, particularly in women with a family history of both colorectal and ovarian cancer.
Genetic testing can help identify women who carry one or more of these high-risk mutations, especially in families with a history of ovarian, breast, or related cancers. For women with a family history of ovarian cancer or other related cancers, genetic testing for BRCA1, BRCA2, and other mutations like Lynch syndrome is an important step in understanding their individual risk.
BRCA1 and BRCA2 mutations are the most well-known genetic risk factors for ovarian cancer, significantly increasing the risk.
Other mutations, such as those in Lynch syndrome genes (MLH1, MSH2, MSH6, PMS2), RAD51C, PALB2, and BRIP1, also elevate the risk of ovarian cancer.
Women with a family history of ovarian cancer or related cancers should consider genetic counseling and testing to understand their risk.
Identifying genetic mutations can help guide preventive measures such as early screening, preventive surgery, or the use of targeted therapies in case of cancer development.
By undergoing genetic testing and understanding the genes associated with ovarian cancer, women can take proactive steps in reducing their risk and improving their chances for early detection and effective treatment.
